(-0.18%) 5 204.50 points
(-0.07%) 38 998 points
(-0.23%) 18 158 points
(-1.20%) $77.44
(2.58%) $2.26
(-0.09%) $2 322.00
(-0.32%) $27.46
(-0.96%) $978.90
(0.10%) $0.930
(0.27%) $10.93
(0.14%) $0.800
(0.52%) $91.91
0.00% HKD 1.200
Live Chart Being Loaded With Signals
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
Dzisiejszy wolumen | 7 000.00 |
Średni wolumen | 751 308 |
Kapitalizacja rynkowa | 1.02B |
EPS | HKD0 ( 2023-08-23 ) |
Następna data zysków | ( HKD0 ) 2024-05-17 |
Last Dividend | HKD0.0300 ( 2023-05-23 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.71 |
ATR14 | HKD0.0130 (1.08%) |
Zhongzhi Pharmaceutical Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zhongzhi Pharmaceutical Finanse
Annual | 2023 |
Przychody: | HKD2.05B |
Zysk brutto: | HKD1.22B (59.43 %) |
EPS: | HKD0.190 |
FY | 2023 |
Przychody: | HKD2.05B |
Zysk brutto: | HKD1.22B (59.43 %) |
EPS: | HKD0.190 |
FY | 2022 |
Przychody: | HKD1.83B |
Zysk brutto: | HKD1.07B (58.45 %) |
EPS: | HKD0.130 |
FY | 2021 |
Przychody: | HKD1.75B |
Zysk brutto: | HKD1.06B (60.78 %) |
EPS: | HKD0.0630 |
Financial Reports:
No articles found.
Zhongzhi Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0300 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0350 | 2016-05-17 |
Last Dividend | HKD0.0300 | 2023-05-23 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | HKD0.282 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.67 | -- |
Div. Sustainability Score | 9.95 | |
Div.Growth Potential Score | 3.75 | |
Div. Directional Score | 6.85 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8617.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
2096.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
1109.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
0163.HK | Ex Dividend Junior | 2023-09-26 | Semi-Annually | 0 | 0.00% | |
3799.HK | Ex Dividend Knight | 2023-05-23 | Semi-Annually | 0 | 0.00% | |
1681.HK | Ex Dividend Knight | 2023-06-08 | Semi-Annually | 0 | 0.00% | |
0711.HK | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% | |
2238.HK | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1257.HK | No Dividend Player | 2023-09-12 | Annually | 0 | 0.00% | |
0305.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0794 | 1.500 | 8.41 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0908 | 1.200 | 6.97 | 8.37 | [0 - 0.3] |
returnOnEquityTTM | 0.154 | 1.500 | 9.40 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.714 | -1.000 | 2.86 | -2.86 | [0 - 1] |
currentRatioTTM | 1.436 | 0.800 | 7.82 | 6.25 | [1 - 3] |
quickRatioTTM | 0.813 | 0.800 | 9.93 | 7.94 | [0.8 - 2.5] |
cashRatioTTM | 0.270 | 1.500 | 9.61 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.126 | -1.500 | 7.91 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0753 | 2.00 | -0.0376 | -0.0753 | [0 - 20] |
debtEquityRatioTTM | 0.215 | -1.500 | 9.14 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.593 | 1.000 | 3.46 | 3.46 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0800 | 1.000 | -0.401 | -0.401 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.451 | 1.000 | 8.61 | 8.61 | [0.2 - 2] |
assetTurnoverTTM | 1.143 | 0.800 | 5.71 | 4.57 | [0.5 - 2] |
Total Score | 9.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.12 | 1.000 | 9.48 | 0 | [1 - 100] |
returnOnEquityTTM | 0.154 | 2.50 | 9.62 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0753 | 2.00 | -0.0251 | -0.0753 | [0 - 30] |
dividendYielPercentageTTM | 8.80 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.714 | 1.500 | 2.86 | -2.86 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0495 | 1.000 | -1.262 | 0 | [0.1 - 0.5] |
Total Score | 3.75 |
Zhongzhi Pharmaceutical
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej